Increasing diagnostic possibilities using the geneLEAD VIII platform for detection of SARS-CoV-2

At the time SARS-CoV-2 was identified as the cause of coronavirus disease 2019 (COVID-19) no in vitro diagnostic (IVD) tests were available since it was a new virus. Very shortly after the release of the genomic sequence of SARS-CoV-2, laboratory-developed tests (LDTs) were developed, made available...

Descripción completa

Detalles Bibliográficos
Autores principales: Boers, Stefan A., Mourik, Bas C., van Bussel, Mario J.A.W.M., de Brouwer, Caroline S., Wessels, Els, Claas, Eric C.J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier B.V. 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457920/
https://www.ncbi.nlm.nih.gov/pubmed/34562515
http://dx.doi.org/10.1016/j.jviromet.2021.114291

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457920/
https://www.ncbi.nlm.nih.gov/pubmed/34562515
http://dx.doi.org/10.1016/j.jviromet.2021.114291

Ejemplares similares